Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | USP2 | O75604 | 1/20 | 0.53 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.49 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.47 |
| ▸ | TAS1R3 | Q7RTX0 | 2/20 | 0.46 |
| ▸ | TAS1R1 | Q7RTX1 | 2/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.43 |
| ▸ | TSHR | P16473 | 1/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | HPGD | P15428 | 2/20 | 0.42 |
| ▸ | TAS1R2 | Q8TE23 | 1/20 | 0.42 |
| ▸ | POLB | P06746 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 2/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2860882 | 1.00 | USP2 (0.53) | USP2SMN1; SMN2EPHX1TAS1R3TAS1R1 | |
| SCHEMBL2866093 | 1.00 | USP2 (0.53) | USP2SMN1; SMN2EPHX1TAS1R3TAS1R1 | |
| SCHEMBL16754965 | 0.87 | TAS1R3 (0.55) | SMN1; SMN2TAS1R3TAS1R1KMT2ATDP1 | |
| SCHEMBL557498 | 0.87 | USP2 (0.53) | USP2SMN1; SMN2EPHX1TAS1R3TAS1R1 | |
| Stearic Acid SCHEMBL3690236 | 0.83 | TRPV1 (0.39) | USP2SMN1; SMN2KMT2ATSHRMEN1 | |
| Stearic Acid SCHEMBL3687284 | 0.83 | TRPV1 (0.39) | USP2SMN1; SMN2KMT2ATSHRMEN1 | |
| Stearic Acid SCHEMBL3696710 | 0.83 | TRPV1 (0.39) | USP2SMN1; SMN2KMT2ATSHRMEN1 | |
| Stearic Acid SCHEMBL3691439 | 0.83 | TRPV1 (0.39) | USP2SMN1; SMN2KMT2ATSHRMEN1 | |
| Stearic Acid SCHEMBL3686276 | 0.83 | TRPV1 (0.39) | USP2SMN1; SMN2KMT2ATSHRMEN1 | |
| SCHEMBL20483598 | 0.81 | USP2 (0.48) | USP2SMN1; SMN2EPHX1TAS1R3TAS1R1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 386 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11733189-B2 | Method for identifying a blend of nucleators useful for preparing a nucleated polyolefin material | NJC EUROPE LIMITED (GB) | 2023-08-22 | — | — | US | claimed |
| EP-4225503-A1 | GRINDING AID FOR TITANIUM DIOXIDE PARTICLES | KRONOS INTERNATIONAL, INC. (DE) | 2023-08-16 | — | — | EP | claimed |
| WO-2022073742-A1 | GRINDING AID FOR TITANIUM DIOXIDE PARTICLES | KRONOS INTERNATIONAL, INC. (DE) | 2022-04-14 | — | — | WO | claimed |
| US-20220106488-A1 | Grinding Aid for Titanium Dioxide Particles | KRONOS INTERNATIONAL INC. (DE) | 2022-04-07 | — | — | US | claimed |
| EP-3854484-A2 | GRINDING AID FOR GRINDING TITANIUM DIOXIDE | Kronos International, Inc. (DE) | 2021-07-28 | — | — | EP | claimed |
| EP-3480273-B1 | ADHESIVE COMPOSITIONS AND USE THEREOF | HENKEL AG & CO KGAA (DE) | 2020-10-07 | — | — | EP | claimed |
| US-20190219528-A1 | METHOD FOR IDENTIFYING A BLEND OF NUCLEATORS USEFUL FOR PREPARING A NUCLEATED POLYOLEFIN MATERIAL | NJC EUROPE LIMITED (GB) | 2019-07-18 | — | — | US | claimed |
| EP-3480273-A1 | ADHESIVE COMPOSITIONS AND USE THEREOF | Henkel AG & Co. KGaA (DE) | 2019-05-08 | — | — | EP | claimed |
| US-9309408-B2 | Additive concentrate and use thereof | HOLLAND COLOURS N.V. (NL) | 2016-04-12 | — | — | US | claimed |
| US-9062184-B2 | Method of preparation of nucleated semi-crystalline polymer | POLYMER INSTITUTE BRNO, SPOL. S.R.O. (CZ) | 2015-06-23 | — | — | US | claimed |
| EP-2625208-A1 | : METHOD OF PREPARATION OF NUCLEATED SEMI-CRYSTALLINE POLYMER | Polymer Institute Brno, Spol. S R.O. (CZ) | 2013-08-14 | — | — | EP | claimed |
| US-20130190435-A1 | METHOD OF PREPARATION OF NUCLEATED SEMI-CRYSTALLINE POLYMER | POLYMER INSTITUTE BRNO, SPOL. S R.O. (CZ) | 2013-07-25 | — | — | US | claimed |
| WO-2012045288-A1 | : METHOD OF PREPARATION OF NUCLEATED SEMI-CRYSTALLINE POLYMER | POLYMER INSTITUTE BRNO, SPOL. S R.O. (CZ) | 2012-04-12 | — | — | WO | claimed |
| EP-1867630-B1 | PROCESS FOR PRODUCING TRICARBOXYLIC ACID TRIS(ALKYL-SUBSTITUTED CYCLOHEXYLAMIDE) | NEW JAPAN CHEM CO LTD (JP) | 2010-10-20 | — | — | EP | claimed |
| US-7745661-B2 | Process for producing tricarboxylic acid tris (alkyl-substituted cyclohexylamide) | NEW JAPAN CHEMICAL CO., LTD. (JP) | 2010-06-29 | — | — | US | claimed |
| US-20090069599-A1 | PROCESS FOR PRODUCING TRICARBOXYLIC ACID TRIS (ALKYL-SUBSTITUTED CYCLOHEXYLAMIDE) | NEW JAPAN CHEMICAL CO., LTD., (JP) | 2009-03-12 | — | — | US | claimed |
| EP-1867630-A1 | PROCESS FOR PRODUCING TRICARBOXYLIC ACID TRIS(ALKYL-SUBSTITUTED CYCLOHEXYLAMIDE) | NEW JAPAN CHEMICAL CO.,LTD. (JP) | 2007-12-19 | — | — | EP | claimed |
| US-5973076-A | MOLDING; CONTROLLING TEMPERATURE IN PRESENCE OF AN AMIDE COMPOUND | NEW JAPAN CHEMICAL CO., LTD. (JP) | 1999-10-26 | — | — | US | claimed |
| EP-0776933-B1 | Polybutene-1 resin composition and a method of accelerating the crystal transformation | NEW JAPAN CHEM CO LTD (JP) | 1999-08-04 | — | — | EP | claimed |
| EP-0776933-A1 | Polybutene-1 resin composition and a method of accelerating the crystal transformation | NEW JAPAN CHEMICAL CO.,LTD. (JP) | 1997-06-04 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090069599-A1 | PROCESS FOR PRODUCING TRICARBOXYLIC ACID TRIS (ALKYL-SUBSTITUTED CYCLOHEXYLAMIDE) | ACMSD, CPS1, COASY | USP2 2432/4885SMN1; SMN2 4288/4885EPHX1 3985/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.